Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Long-term Study on the Safety and Efficacy of Efgartigimod in Adults with Primary Immune Thrombocytopenia
CzechiaStudy on the Effects of Inebilizumab for Adults with Myasthenia Gravis
FranceStudy on the Effects of Oxygen Therapy with Vedolizumab, Ustekinumab, or Infliximab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy on Reversing HIV Latency Using Pyrimethamine, Lenalidomide, and Panobinostat for People Living with HIV
The NetherlandsStudy on the Effectiveness and Safety of CAEL-101 with Drug Combination for Patients with Advanced AL Amyloidosis
AustriaStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
AustriaStudy on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
CzechiaStudy on Azithromycin and Doxycycline for Reducing Inflammation in Sarcoidosis Patients
The NetherlandsStudy on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns
SpainStudy on NTLA-2002 for Adults with Hereditary Angioedema Using Ziclumeran and Lonvoguran
FranceStudy on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis
AustriaStudy on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
